Arrowhead Pharmaceuticals
ARWR
#2176
Rank
S$11.00 B
Marketcap
S$79.62
Share price
-4.98%
Change (1 day)
166.74%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total debt

Total debt on the balance sheet as of June 2025 : S$0.45 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total debt is S$0.45 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Arrowhead Pharmaceuticals - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-09-30S$0.65 B317%
2023-09-30S$0.15 B34.37%
2022-09-30S$0.11 B237.48%
2021-09-30S$34.69 M20.28%
2020-09-30S$28.84 M
2019-09-30N/A-100%
2018-09-30S$3.17 M-7.68%
2017-09-30S$3.44 M-7.47%
2016-09-30S$3.72 M244.74%
2015-09-30S$1.07 M-17.24%
2014-09-30S$1.3 M-54.89%
2013-09-30S$2.89 M-3.43%
2012-09-30S$2.99 M279.96%
2011-09-30S$0.78 M19.83%
2010-09-30S$0.65 M-62.12%
2009-09-30S$1.73 M-21.39%
2008-09-30S$2.2 M
2002-09-30S$1.12 M14.12%
2001-09-30S$0.98 M0.75%
2000-09-30S$0.97 M2%
1999-09-30S$0.96 M-46.83%
1998-09-30S$1.8 M15.26%
1997-09-30S$1.56 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Alnylam Pharmaceuticals
ALNY
S$1.69 B 270.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.58 B 27.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
S$12.98 M-97.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$59.34 B 12,871.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
S$0.95 B 107.91%๐Ÿ‡บ๐Ÿ‡ธ USA